Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells

Condition:   Immune Response Interventions:   Biological: MV130;   Other: Placebo Sponsor:   Inmunotek S.L. Not yet recruiting

Source: ClinicalTrials.gov - January 26, 2022 Category: Research Source Type: clinical trials